InternationalResearch and clinical trials
International expert recommendations published for crises in maple syrup urine disease
A study published in a journal and reviewed by independent scientists. Even so, a single study is not conclusive; it needs to be replicated.
Eight expert physicians prepared a roadmap for sudden crises in maple syrup urine disease. During a crisis, leucine in the blood must be lowered quickly, and attention must be paid to brain swelling. Treatment should be given by an experienced team. In Europe, a fluid given into a vein that does not contain these amino acids has been approved. In suitable patients, liver transplantation is also an option.
What does it mean for patients and families?
Know in advance which center to go to during a crisis. Make an emergency plan together with your treatment team.
Source
Scientific paper: Management of acute metabolic decompensation in maple syrup urine disease: guidance based on international clinical practice. Orphanet Journal of Rare Diseases, 2026. DOI: 10.1186/s13023-026-04418-y · PubMed 42251408
The source page was opened and read on October 7, 2026. Summary prepared by the Doktorclub editorial team and translated from Turkish; it has not yet been reviewed by a physician (a scientific board is being set up).
This page is translated from the Turkish original.
Related disease: Maple syrup urine disease (MSUD)
This page reports a development; it is not a treatment recommendation. Your doctor decides whether a treatment is right for you.